Entrada Therapeutics

TRDANasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$267.495 M

$6.87 +0.00%

Close of 7 Aug 2026

Revenue

$25.4M

#2936 by revenue

Earnings

-$143.8M

Loss-making

Shares outstanding

38,936,669

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#245Veraxa BiotechVRXA$281.4M
#246AdageneADAG$271.5M
#247Entrada TherapeuticsTRDA$267.5M
#248Camp4 TherapeuticsCAMP$265.9M
#249ProQR TherapeuticsPRQR$264.6M

Where these numbers come from

Share counts and financials for Entrada Therapeutics are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.